Abstract
The therapeutic potential of isovolaemic haemodilution and osmotherapy on the sequelae of middle cerebral artery occlusion has been studied in an animal model. The territory of the middle cerebral artery that failed to fill with a carbon black intravascular marker after intracranial occlusion for 30 minutes in the anaesthetised rat was reduced by 50% by isovolaemic haemodilution to a haematocrit of 30%. An intravenous infusion of 10% glycerol prevented swelling of the ischaemic hemisphere, though it did not further improve vascular perfusion. These findings support the use of isovolaemic haemodilution and osmotherapy in the acute aftermath of stroke.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brown M. M., Wade J. P., Marshall J. Fundamental importance of arterial oxygen content in the regulation of cerebral blood flow in man. Brain. 1985 Mar;108(Pt 1):81–93. doi: 10.1093/brain/108.1.81. [DOI] [PubMed] [Google Scholar]
- Harrison M. J., Arnold J., Sedal L., Russell R. W. Ischaemic swelling of cerebral hemisphere in the gerbil. J Neurol Neurosurg Psychiatry. 1975 Dec;38(12):1194–1196. doi: 10.1136/jnnp.38.12.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harrison M. J., Pollock S., Kendall B. E., Marshall J. Effect of haematocrit on carotid stenosis and cerebral infarction. Lancet. 1981 Jul 18;2(8238):114–115. doi: 10.1016/s0140-6736(81)90298-1. [DOI] [PubMed] [Google Scholar]
- Kannel W. B., Gordon T., Wolf P. A., McNamara P. Hemoglobin and the risk of cerebral infarction: the Framingham Study. Stroke. 1972 Jul-Aug;3(4):409–420. doi: 10.1161/01.str.3.4.409. [DOI] [PubMed] [Google Scholar]
- Mathew N. T., Rivera V. M., Meyer J. S., Charney J. Z., Hartmann A. Double-blind evaluation of glycerol therapy in acute cerebral infarction. Lancet. 1972 Dec 23;2(7791):1327–1329. doi: 10.1016/s0140-6736(72)92775-4. [DOI] [PubMed] [Google Scholar]
- Mulley G., Wilcox R. G., Mitchell J. R. Dexamethasone in acute stroke. Br Med J. 1978 Oct 7;2(6143):994–996. doi: 10.1136/bmj.2.6143.994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Strand T., Asplund K., Eriksson S., Hägg E., Lithner F., Wester P. O. A randomized controlled trial of hemodilution therapy in acute ischemic stroke. Stroke. 1984 Nov-Dec;15(6):980–989. doi: 10.1161/01.str.15.6.980. [DOI] [PubMed] [Google Scholar]
- Sundt T. M., Jr, Waltz A. G., Sayre G. P. Experimental cerebral infarction: modification by treatment with hemodiluting, hemoconcentrating, and dehydrating agents. J Neurosurg. 1967 Jan;26(1):46–56. doi: 10.3171/jns.1967.26.1part1.0046. [DOI] [PubMed] [Google Scholar]
- Tohgi H., Yamanouchi H., Murakami M., Kameyama M. Importance of the hematocrit as a risk factor in cerebral infarction. Stroke. 1978 Jul-Aug;9(4):369–374. doi: 10.1161/01.str.9.4.369. [DOI] [PubMed] [Google Scholar]
- White O. B., Norris J. W., Hachinski V. C., Lewis A. Death in early stroke, causes and mechanisms. Stroke. 1979 Nov-Dec;10(6):743–743. doi: 10.1161/01.str.10.6.743. [DOI] [PubMed] [Google Scholar]